Mostrando 2 resultados de: 2
Masitinib for the treatment of mild to moderate Alzheimer's disease
ReviewAbstract: Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of dePalabras claves:ALZHÉIMER, inflammation, masitinib, Neurodegeneration, TauAutores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Lazarowski A., Miguel Marin, Olloquequi J., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusMavoglurant as a treatment for Parkinson's disease
ReviewAbstract: Introduction: A major unresolved issue in the Parkinson's disease (PD) treatment is the developmentPalabras claves:L-Dopa, Mavoglurant, Mlgu5, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., De Lemos M.L., Folch J., Lazarowski A., Pallás M., Pedros I., Petrov D., Zárate C.B.Fuentes:scopus